- Home
- SKLZ vs CRBU Comparison
SKLZ vs CRBU Comparison
Compare SKLZ & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKLZ
- CRBU
- Stock Information
- Founded
- SKLZ 2012
- CRBU 2011
- Country
- SKLZ United States
- CRBU United States
- Employees
- SKLZ N/A
- CRBU N/A
- Industry
- SKLZ EDP Services
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- SKLZ Technology
- CRBU Health Care
- Exchange
- SKLZ Nasdaq
- CRBU Nasdaq
- Market Cap
- SKLZ 95.6M
- CRBU 93.0M
- IPO Year
- SKLZ N/A
- CRBU 2021
- Fundamental
- Price
- SKLZ $4.48
- CRBU $0.91
- Analyst Decision
- SKLZ Buy
- CRBU Strong Buy
- Analyst Count
- SKLZ 2
- CRBU 5
- Target Price
- SKLZ $10.75
- CRBU $11.80
- AVG Volume (30 Days)
- SKLZ 82.7K
- CRBU 983.0K
- Earning Date
- SKLZ 03-13-2025
- CRBU 03-10-2025
- Dividend Yield
- SKLZ N/A
- CRBU N/A
- EPS Growth
- SKLZ N/A
- CRBU N/A
- EPS
- SKLZ N/A
- CRBU N/A
- Revenue
- SKLZ $95,466,000.00
- CRBU $9,994,000.00
- Revenue This Year
- SKLZ $13.20
- CRBU $3.50
- Revenue Next Year
- SKLZ $10.35
- CRBU $177.84
- P/E Ratio
- SKLZ N/A
- CRBU N/A
- Revenue Growth
- SKLZ N/A
- CRBU N/A
- 52 Week Low
- SKLZ $4.33
- CRBU $0.88
- 52 Week High
- SKLZ $7.48
- CRBU $5.15
- Technical
- Relative Strength Index (RSI)
- SKLZ 34.93
- CRBU 36.05
- Support Level
- SKLZ $4.44
- CRBU $0.88
- Resistance Level
- SKLZ $5.04
- CRBU $1.01
- Average True Range (ATR)
- SKLZ 0.29
- CRBU 0.08
- MACD
- SKLZ 0.00
- CRBU 0.00
- Stochastic Oscillator
- SKLZ 11.02
- CRBU 14.39
About SKLZ Skillz Inc.
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.